Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada
Clicks: 391
ID: 274765
1999
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
391 views
36 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #29 of 105 articles by views in Antimicrobial agents and chemotherapy
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
A total of 3,205 group A streptoccal isolates were collected in 1997 through a private laboratory which serves community physicians in southern Ontario and which represents a population base of 6 million people. Nonsusceptibility to erythromycin was detected for 67 (2.1%) isolates both by disk diffu …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (41 words).
Try re-searching for a better abstract.
| Reference Key |
jc1999antimicrobialprevalence
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | De Azavedo JC;Yeung RH;Bast DJ;Duncan CL;Borgia SB;Low DE;; |
| Journal | Antimicrobial agents and chemotherapy |
| Year | 1999 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
gel
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
phenotype
Genotype
drug resistance
microbial sensitivity tests
anti-bacterial agents / pharmacology*
streptococcus pyogenes / isolation & purification
electrophoresis
pulsed-field
streptococcus pyogenes / drug effects*
prevalence
microbial / genetics
ontario
streptococcus pyogenes / classification
d e low
erythromycin / pharmacology*
streptococcus pyogenes / genetics*
pmid:10471555
pmc89437
doi:10.1128/aac.43.9.2144
j c de azavedo
r h yeung
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.